In colorectal cancer, the histone deacetylase inhibitor trichostatin A (TSA) effectively reverses the downregulation of CNT2 expression mediated by histone deacetylation and enhances the sensitivity of colorectal cancer cells to the chemotherapeutic drug cladribine (196). The gene discussed is SLC28A2; the disease is colorectal cancer.